Co-Authors
This is a "connection" page, showing publications co-authored by Ranjit Sah and Ruchi Tiwari.
Connection Strength
1.136
-
COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic. Travel Med Infect Dis. 2021 May-Jun; 41:102037.
Score: 0.234
-
COVID-19: animals, veterinary and zoonotic links. Vet Q. 2020 Dec; 40(1):169-182.
Score: 0.229
-
Immunopathogenesis and immunobiology of SARS-CoV-2. Infez Med. 2021 Jun 01; 29(2):167-180.
Score: 0.059
-
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review. Hum Vaccin Immunother. 2021 07 03; 17(7):1897-1909.
Score: 0.058
-
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. Ann Clin Microbiol Antimicrob. 2021 Jan 18; 20(1):8.
Score: 0.058
-
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann Clin Microbiol Antimicrob. 2020 Sep 02; 19(1):40.
Score: 0.056
-
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med Infect Dis. 2020 Sep - Oct; 37:101830.
Score: 0.056
-
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum Vaccin Immunother. 2020 12 01; 16(12):2891-2904.
Score: 0.056
-
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens. 2020 06 28; 9(7).
Score: 0.056
-
A vaccine is not too far for COVID-19. J Infect Dev Ctries. 2020 May 31; 14(5):450-453.
Score: 0.055
-
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clin Microbiol Antimicrob. 2020 05 30; 19(1):23.
Score: 0.055
-
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Med Infect Dis. 2020 Sep - Oct; 37:101755.
Score: 0.055
-
Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools. Arch Med Res. 2020 07; 51(5):450-452.
Score: 0.055
-
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview Infez Med. 2020 Ahead Of Print Jun 1; 28(2):174-184.
Score: 0.054